Krista Meyer

3 Patents

• US122303982025

  Predictive Test for Patient Benefit from Antibody Drug Blocking Ligand Activation of the T-cell Programmed Cell Death 1 (PD-1) Checkpoint Protein and Classifier Development Methods

  BIODESIX, Inc.

  0 cites
• US117105392023

  Predictive Test for Melanoma Patient Benefit from Interleukin-2 (IL2) Therapy

  BIODESIX, Inc.

  0 cites
• US116210572023

  Classifier Generation Methods and Predictive Test for Ovarian Cancer Patient Prognosis Under Platinum Chemotherapy

  BIODESIX, Inc.

  0 cites